Loading...

Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment

Despite treatment of patients with metastatic colorectal cancer (mCRC) with bevacizumab plus chemotherapy, response rates are modest and there are no biomarkers available that will predict response. The aim of this study was to assess if markers associated with three interconnected cancer-associated...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Noonan, Sinead A., Morrissey, Maria E., Martin, Petra, Biniecka, Monika, Ó'Meachair, Shane, Maguire, Aoife, Tosetto, Miriam, Nolan, Blathnaid, Hyland, John, Sheahan, Kieran, O'Donoghue, Diarmuid, Mulcahy, Hugh, Fennelly, David, O'Sullivan, Jacintha
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828217/
https://ncbi.nlm.nih.gov/pubmed/29535825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24276
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!